Vizimpro

List of products in the National Drug Code with proprietary name vizimpro. Dacomitinib is used to treat a certain type of lung cancer (non-small cell lung cancer). It works by slowing or stopping the growth of cancer cells.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0069-0197Vizimpro DacomitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1198Vizimpro DacomitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-2299Vizimpro DacomitinibTablet, Film CoatedOralPfizer Laboratories Div Pfizer IncHuman Prescription Drug
63539-197Vizimpro DacomitinibTablet, Film CoatedOralU.s. PharmaceuticalsHuman Prescription Drug